Methylmalonic Acid, a Biochemical Hallmark of Methylmalonic Acidurias but No Inhibitor of Mitochondrial Respiratory Chain

Methylmalonic acidurias are biochemically characterized by an accumulation of methylmalonic acid and alternative metabolites. An impairment of energy metabolism plays a key role in the pathophysiology of this disease, resulting in neurodegeneration of the basal ganglia and renal failure. It has become the subject of intense debates whether methylmalonic acid is the major toxin, inhibiting respiratory chain complex II. To elucidate whether methylmalonic acid is a respiratory chain inhibitor, we used spectrophotometric analysis of complex II activity in submitochondrial particles from bovine heart, radiometric analysis of 14C-labeled substrates (pyruvate, malate, succinate), and analysis of ATP production in muscle from mice. Methylmalonic acid revealed no direct effects on the respiratory chain function, i.e. on single electron transferring complexes I-IV, ATPase, and mitochondrial transporters. However, we identified a variety of variables that must be carefully controlled to avoid an artificial inhibition of complex II activity. In summary, the study verifies our hypothesis that methylmalonic acid is not the major toxic metabolite in methylmalonic acidurias. Inhibition of respiratory chain and tricarboxylic acid cycle is most likely induced by synergistically acting alternative metabolites, in particular 2-methylcitric acid, malonic acid, and propionyl-CoA. Methylmalonic acidurias are biochemically characterized by an accumulation of methylmalonic acid and alternative metabolites. An impairment of energy metabolism plays a key role in the pathophysiology of this disease, resulting in neurodegeneration of the basal ganglia and renal failure. It has become the subject of intense debates whether methylmalonic acid is the major toxin, inhibiting respiratory chain complex II. To elucidate whether methylmalonic acid is a respiratory chain inhibitor, we used spectrophotometric analysis of complex II activity in submitochondrial particles from bovine heart, radiometric analysis of 14C-labeled substrates (pyruvate, malate, succinate), and analysis of ATP production in muscle from mice. Methylmalonic acid revealed no direct effects on the respiratory chain function, i.e. on single electron transferring complexes I-IV, ATPase, and mitochondrial transporters. However, we identified a variety of variables that must be carefully controlled to avoid an artificial inhibition of complex II activity. In summary, the study verifies our hypothesis that methylmalonic acid is not the major toxic metabolite in methylmalonic acidurias. Inhibition of respiratory chain and tricarboxylic acid cycle is most likely induced by synergistically acting alternative metabolites, in particular 2-methylcitric acid, malonic acid, and propionyl-CoA. Methylmalonic acidurias are biochemically characterized by an accumulation of methylmalonic acid in tissues and body fluids (1Fenton W.A. Gravel R.A. Rosenblatt D.S. Scriver C.R. Beaudet A.L. Valle A.D. Sly W.S. The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill Inc., New York2001: 2165-2193Google Scholar). They are caused by an inherited deficiency of the mitochondrial enzyme methylmalonyl-CoA mutase (EC 5.4.99.2) or by defects in the synthesis of 5′-deoxyadenosylcobalamin, the cofactor of methylmalonyl-CoA mutase (2Mahoney M.J. Hart A.C. Stehen V.D. Rosenberg L.E. Proc. Natl. Acad. Sci. U. S. A. 1975; 72: 2799-2803Crossref PubMed Scopus (60) Google Scholar, 3Ledley F.D. Lumetta M.R. Zoghbi H.Y. van Tuinen P. Ledbetter S.A. Ledbetter D.H. Am. J. Hum. Genet. 1998; 42: 839-846Google Scholar). Although the etiology of methylmalonic acidurias is heterogeneous, the clinical presentation of affected patients is similar. At disease onset, lethargy, failure to thrive, recurrent vomiting, dehydration, respiratory distress, muscular hypotonia, hepatomegaly, and coma are common clinical features. In addition, impaired psychomotor development is an important sequel. Despite improvement of treatment during the last 20 years, the overall outcome of these patients remains disappointing, e.g. there is growing evidence for the development of long term neurological deficits (4van der Meer S.B. Poggi F. Spada M. Bonnefont J.P. Ogier H. Hubert P. Depondt E. Rapoport D. Rabier D. Charpentier C. Parvy P. Bardet J. Kamoun P. Saudubray J.M. J. Pediatr. 1994; 125: 903-908Abstract Full Text Full Text PDF PubMed Scopus (116) Google Scholar) mostly affecting the globus pallidus (5Brismar J. Ozand P.T. Am. J. Neuroradiol. 1994; 15: 1459-1473PubMed Google Scholar, 6Larnaout A. Mongalgi M.A. Kaabachi N. Khiari D. Debbabi A. Mebazza A. Ben Hamida M. Hentati F. J. Inherited Metab. Dis. 1998; 21: 639-644Crossref PubMed Scopus (28) Google Scholar). It has been suggested that these pathological changes are caused by “metabolic stroke” due to accumulating toxic organic acids (7Heidenreich R. Natowicz M. Hainline B.E. Berman P. Kelley R.I. Hillman R.E. Berry G.T. J. Pediatr. 1988; 113: 1022-1027Abstract Full Text PDF PubMed Scopus (129) Google Scholar). A recent study has supported this hypothesis, demonstrating restricted diffusion and elevated amounts of lactate in the globus pallidus of affected patients signaling mitochondrial dysfunction (8Trinh B.C. Melhem E.R. Barker P.B. Am. J. Neuroradiol. 2001; 22: 831-833PubMed Google Scholar). Notably, symmetrical lesions in globus pallidus are also found in patients with inherited complex II deficiency and other respiratory chain disorders (9Martin J.J. van de Vyver F.L. Scholte H.R. Roodhooft A.M. Martin C.C. Luyt-Houwen L.E. J. Neurol. Sci. 1988; 84: 189-200Abstract Full Text PDF PubMed Scopus (32) Google Scholar). Although a contribution of toxic organic acids to the neuropathogenesis of methylmalonic acidurias was suggested more than a decade ago, it remains unclear which is the main neurotoxic metabolite in this condition. MMA, 1The abbreviations used are: MMAmethylmalonic acidMAmalonic acidCAPS3-(cyclo-hexylamino)propanesulfonic acidCHES2-(cyclohexylamino)ethanesulfonic acidEPPS4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acidMES4-morpholinepropanesulfonic acidMMAmethylmalonic acidMOPS4-morpholinepropanesulfonic acidSMPsubmitochondrial particle from bovine heart. which reaches millimolar concentrations in body fluids and brain tissue during acute metabolic crises, was first suggested to act as an endogenous toxic metabolite, mediating neuronal damage via inhibition of mitochondrial energy metabolism (10Dutra J.C. Dutra-Filho C.S. Cardozo S.E.C. Wannmacher C.M.D. Sarkis J.J.F. Wajner M. J. Inherited Metab. Dis. 1993; 16: 147-153Crossref PubMed Scopus (70) Google Scholar, 11Brusque A.M. Borba Rosa R. Schluck P.F. Dalcin K.B. Ribeiro C.A. Silva C.G. Wannmacher C.M. Dutra-Filho C.S. Wyse A.T. Briones P. Wajner M. Neurochem. Int. 2002; 40: 593-601Crossref PubMed Scopus (101) Google Scholar). It has been hypothesized that MMA induced inhibition of complex II (synonym, succinate:ubiquinone oxidoreductase), a multiprotein assembly imparted in the tricarboxylic acid cycle and the mitochondrial respiratory chain, has become a focus of interest (12Wajner M. Coelho J.C. J. Inherited Metab. Dis. 1997; 20: 761-768Crossref PubMed Scopus (68) Google Scholar). MMA induced cell damage in different neuronal culture systems (13McLaughlin B.A. Nelson D. Silver J.A. Erecinska M. Chesselet M.F. Neuroscience. 1998; 86: 276-290Crossref Scopus (95) Google Scholar, 14Kölker S. Ahlemeyer B. Krieglstein J. Hoffmann G.F. J. Inherited Metab. Dis. 2000; 23: 355-358Crossref PubMed Scopus (27) Google Scholar, 15Okun J.G. Hörster F. Farkas L.M. Feyh P. Hinz A. Sauer S. Hoffmann G.F. Unsicker K. Mayatepek E. Kölker S. J. Biol. Chem. 2002; 277: 14674-14680Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar) and evokes rotational behavior, seizures, and striatal lesions in rats after intrastriatal administration (16de Mello C.F. Begnini J. Jimenez-Bernal R.E. Rubin M.A. de Bastiani J. da Costa Jr., E. Wajner M. Brain Res. 1996; 721: 120-125Crossref PubMed Scopus (68) Google Scholar, 17Narasimhan P. Sklar R. Murrell M. Swanson R.A. Sharp F.R. J. Neurosci. 1996; 16: 7336-7346Crossref PubMed Google Scholar). MMA-induced changes were prevented by succinate, antagonists of ionotropic glutamate receptors, and antioxidants (15Okun J.G. Hörster F. Farkas L.M. Feyh P. Hinz A. Sauer S. Hoffmann G.F. Unsicker K. Mayatepek E. Kölker S. J. Biol. Chem. 2002; 277: 14674-14680Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar, 16de Mello C.F. Begnini J. Jimenez-Bernal R.E. Rubin M.A. de Bastiani J. da Costa Jr., E. Wajner M. Brain Res. 1996; 721: 120-125Crossref PubMed Scopus (68) Google Scholar, 18Fighera M.R. Queiroz C.M. Stracke M.P. Brauer M.C. Gonzalez-Rodriquez L.L. Frussa-Filho R. Wajner M. de Mello C.F. Neuroreport. 1999; 10: 2039-2043Crossref PubMed Scopus (65) Google Scholar). Consequently, MMA has been suggested to induce so-called “secondary” or “weak” excitotoxicity (12Wajner M. Coelho J.C. J. Inherited Metab. Dis. 1997; 20: 761-768Crossref PubMed Scopus (68) Google Scholar, 19Albin R.L. Greenamyre J.T. Neurology. 1992; 42: 733-738Crossref PubMed Google Scholar). methylmalonic acid malonic acid 3-(cyclo-hexylamino)propanesulfonic acid 2-(cyclohexylamino)ethanesulfonic acid 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid 4-morpholinepropanesulfonic acid methylmalonic acid 4-morpholinepropanesulfonic acid submitochondrial particle from bovine heart. However, recently we have demonstrated in striatal neuronal cultures from rat embryos that MMA-induced neuronal damage involves intracellular formation of the competitive complex II inhibitor malonate (MA) and 2-methylcitrate, a compound with multiple inhibitory properties on the tricarboxylic acid cycle (15Okun J.G. Hörster F. Farkas L.M. Feyh P. Hinz A. Sauer S. Hoffmann G.F. Unsicker K. Mayatepek E. Kölker S. J. Biol. Chem. 2002; 277: 14674-14680Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar). Therefore, we suggest that neuronal damage is mainly driven via metabolites that derive from alternative oxidation pathways of propionyl-CoA rather than by MMA itself. In the present study we investigated whether MMA exerted any direct effects on mitochondrial energy metabolism and have investigated in detail the susceptibility of respiratory activity measurements to distinct artifacts. By this approach we can provide further evidence for our previous hypothesis that inhibition of the respiratory chain is not directly induced by MMA. Spectrophotometric Assay for Complex II Activity in Submitochondrial Particles—Submitochondrial particles from bovine heart were prepared as previously described (20Okun J.G. Lümmen P. Brandt U. J. Biol. Chem. 1999; 274: 2625-2630Abstract Full Text Full Text PDF PubMed Scopus (298) Google Scholar). Protein was determined according to Lowry et al. (21Lowry O.H. Roseborough N.R. Farr A.J. J. Biol. Chem. 1951; 193: 265-275Abstract Full Text PDF PubMed Google Scholar) with modifications of Helenius and Simons (22Helenius A. Simons K. J. Biol. Chem. 1972; 247: 3656-3661Abstract Full Text PDF PubMed Google Scholar) using bovine serum albumin as the standard. The catalytic activity of respiratory chain complex II was investigated in submitochondrial particles (SMPs) from bovine heart as previously described using decylubiquinone as the electron mediator (15Okun J.G. Hörster F. Farkas L.M. Feyh P. Hinz A. Sauer S. Hoffmann G.F. Unsicker K. Mayatepek E. Kölker S. J. Biol. Chem. 2002; 277: 14674-14680Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar, 23Kölker S. Okun J.G. Hörster F. Assmann B. Kohlmüller D. Exner-Camps S. Ahlemeyer B. Mayatepek E. Krieglstein J. Hoffmann G.F. J. Neurosci. Res. 2001; 66: 666-673Crossref PubMed Scopus (33) Google Scholar). In brief, steady state activities of mitochondrial complex II were recorded using a computer tunable spectrophotometer (SPECTRAmax Plus 384 Microplate Reader, Molecular Devices, Sunnyvale, CA) operating in the dual wavelength mode. Reduction of 2,6-dichlorophenolindophenol was detected at 610–750 nm (ϵ = 22.0 mmol/liter–1 × cm–1) in thermostatted 96-well plates in a final volume of 300 μl (n = 8–16 experiments). Measurements were performed at standard conditions, which are defined as follows: SMPs were diluted to a final protein concentration of 2.5 mg/ml in 250 mm sucrose, 50 mm KCl, 5 mm MgCl2, 20 mm TRIS/HCl (pH 7.4), 2 mm NaN3, and 20 mm sodium succinate. SMP dilution was incubated for 10 min at 37 °C. Thereafter, 15 μg of SMPs were added into each well. The reaction was started by the addition of a 300-μl reaction mixture containing 50 mm TRIS/HCl (adjusted to pH 7.4), 20 mm sodium succinate, 2 mm NaN3, 60 mm 2,6-dichlorophenolindophenol with 0.01% Triton X-100, and 40 μm decylubiquinone. SMP dilution was kept on ice between measurements. In each experimental series, the specificity of the measured complex II activity was determined by using the specific inhibitor thenoyltrifluoroacetone (8 mm). In analogy, the effects of the competitive complex II inhibitor malonate (MA) and the structurally related compound MMA were investigated using concentrations of up to 10 mm. To examine competition between these compounds with succinate at complex II, MA and MMA were incubated with different succinate concentrations (up to 20 mm) in the reaction mixture. Furthermore, we compared the effect of MMA on complex II activity after a 30-min incubation with 3-nitropropionic acid, a well known “suicide” inhibitor of complex II (24Beal M.F. Brouillet E. Jenkins B.G. Ferrante R.J. Kowall N.W. Miller J.M. Storey E. Srivastava R. Rosen B.R. Hyman B. J. Neurosci. 1993; 13: 4181-4191Crossref PubMed Google Scholar). Complex II activity is modulated by a variety of variables, probably resulting in an artificial inhibition of this mitochondrial complex under non-standardized conditions. Because oxaloacetate inhibits complex II, we investigated the effects of “aging” on complex II activity in our assay, determining complex II activity during a period of up to 140 min. The effects of non-standardized conditions were tested by varying succinate concentrations, time points of measurement, and temperature at which SMP dilution was kept. Furthermore, we investigated the pH dependence of complex II activity at pH 5–10, replacing TRIS/HCl by 50 mm concentrations of a multi-buffer mixture, containing 10 mm of CAPS, MES, CHES, EPPS, and MOPS. pH optimum was determined according to Brandt and Okun (25Brandt U. Okun J.G. Biochemistry. 1997; 36: 11234-11240Crossref PubMed Scopus (89) Google Scholar). Furthermore, the effects of buffered and unbuffered MMA on complex II activity were tested. Preparation of 600 × g Supernatants from Muscle—Adult C57Bl/6 mice of both sexes (n = 6) were sacrificed for the experiments. Immediately after death, muscle specimens (muscle quadriceps) were removed and homogenized (10% w/v). 600 × g supernatants were prepared according to Fisher et al. (26Fisher J.C. Ruitenbeek W. Stadhouders A.M. Trijbels J.M.F. Sengers R.C.A. Janssen A.J.M. Veerkamp J.H. Clin. Chim. Acta. 1985; 145: 89-100Crossref PubMed Scopus (65) Google Scholar). Immediately after centrifugation, oxidation rates of [1-14C]pyruvate, [U-14C]malate, and [1,4-14C]succinate and ATP production of unlabeled pyruvate, malate, and succinate were determined (27Trijbels J.M.F. Sengers R.C.A. Ruitenbeek W. Fischer J.C. Bakkeren J. Janssen A.J.M. Eur. J. Pediatr. 1988; 148: 92-97Crossref PubMed Scopus (60) Google Scholar, 28Sperl W. Trijbels J.M.F. Ruitenbeek W. van Laack H.L.J.M. Janssen A.J.M. Kerkhof C.M.C. Sengers R.C.A. Enzyme Protein. 1993; 47: 37-46Crossref PubMed Scopus (28) Google Scholar). Aliquots of the supernatants were frozen and kept at –80 °C until measurement of protein concentrations (21Lowry O.H. Roseborough N.R. Farr A.J. J. Biol. Chem. 1951; 193: 265-275Abstract Full Text PDF PubMed Google Scholar, 22Helenius A. Simons K. J. Biol. Chem. 1972; 247: 3656-3661Abstract Full Text PDF PubMed Google Scholar) and citrate synthase activity (29Srere P.A. Löwenstein J.M. Methods in Enzymology. Academic Press, Inc., London1969: 3-11Google Scholar). Animal care followed the official governmental guidelines and was approved by the government ethics committee. Radiometric Analysis of Mitochondrial Oxidative Phosphorylation— Analysis of single respiratory chain complexes does not allow detection effects of toxic compounds on associated proteins and transporters of the mitochondrial respiratory chain but can be detected by radiometric analysis of 14C-labeled substrates. Radiometric analysis of oxidation rates of [1-14C]pyruvate, [U-14C]malate, and [1,4-14C]succinate were determined as previously described (27Trijbels J.M.F. Sengers R.C.A. Ruitenbeek W. Fischer J.C. Bakkeren J. Janssen A.J.M. Eur. J. Pediatr. 1988; 148: 92-97Crossref PubMed Scopus (60) Google Scholar, 28Sperl W. Trijbels J.M.F. Ruitenbeek W. van Laack H.L.J.M. Janssen A.J.M. Kerkhof C.M.C. Sengers R.C.A. Enzyme Protein. 1993; 47: 37-46Crossref PubMed Scopus (28) Google Scholar). We investigated whether mitochondrial respiration and oxidative phosphorylation was influenced by MMA (1 mm). An overview on the experiments performed is given in Table I.Table IExperimental protocol for the radiometric analysis of [1-14C]pyruvate, [U-14C]malate and [1,4-14C]succinate in 600 × g supernatants from muscle tissue of adult C57Bl/6 miceWithout MMAWith MMA (1 mm)Pyruvate oxidation [1-14C]Pyruvate+ Malate+ Malate+ Carnitine+ Carnitine+ Malate - ADP+ Malate - ADP+ Malate - ADP + CCCP+ Malate - ADP + CCCP+ Malate - ADP + atractylosideMalate oxidation [U-14C] Malate+ Pyruvate+ Pyruvate+ Pyruvate + malonate+ Acetylcarnitine+ Acetylcarnitine+ Acetylcarnitine + malonate+ Acetylcarnitine + arseniteSuccinate oxidation [1,4-14C]Succinate+ Acetylcarnitine+ Acetylcarnitine+ Acetylcarnitine + malonate Open table in a new tab ATP Production—ATP production was determined with unlabeled pyruvate, malate, and succinate as described previously (30Ruitenbeek W. Sengers R.C.A. Trijbels J.M.F. Stadhouders A.M. Janssen A.J.M. J. Inherited Metab. Dis. 1981; 4: 91-92Crossref PubMed Scopus (16) Google Scholar). Spectrophotometric measurement of ATP production is coupled to the formation of NADPH (λ = 320–400 nm, 25 °C). The test principle consists of two enzyme reactions. In the first step, glucose (30.3 mm) and ATP are catalyzed to glucose 6-phosphate and ADP by hexokinase. Subsequently, glucose 6-phosphate dehydrogenase catalyzes glucose 6-phosphate and NADP+ to 6-phosphoglucolacton and NADPH. The production of NADPH was normalized to the protein concentration and citrate synthase activity of each sample. An overview on the experiments performed is shown in Table II.Table IIExperimental protocol for the analysis of pyruvate- and succinate-stimulated ATP production in 600 × g supernatants from muscle tissue of adult C57Bl/6 miceWithout MMAWith MMA (1 mm)Pyruvate Pyruvate+ Malate+ malate+ Malate + arsenite+ Malate + CCCP+ malate + CCCPSuccinate Succinate+ Acetylcarnitine + DQA + antimycin A+ Acetylcamitine + DQA - antimycin A+ acetylcarnitine + DQA - antimycin A+ acetylcamitine - antimycin A Open table in a new tab Data Analysis—Data were normalized to citrate synthase activity and protein concentrations of the same sample. If not explicitly mentioned, MMA-induced effects on complex II activity were normalized to simultaneously measured controls. This procedure was compared with a different normalization procedure using a control group that was measured at the beginning of each experimental series (see Fig. 4A). Data were expressed as the mean ± S.E. Experiments were performed 6–8-fold. One-way analysis of variance followed by Scheffe's test (for three or more groups), or Student's t test (for two groups) were calculated using SPSS for Windows 10.0 software. p < 0.05 was considered significant. pH dependence of complex II activity was analyzed using the Psiplot software 5.02a. Methylmalonic Acid Does Not Inhibit Complex II Activity in SMPs—In SMP complex II revealed a high activity (Vmax, 1.02 units/mg of protein, n = 8), a high affinity for the substrate succinate (Km: 40 μm, n = 8), and a good inhibitory response to the standard inhibitor thenoyltrifluoroacetone (8 mm; 10% of control activity, n = 8). Varying the absolute and relative concentrations of MMA (0, 0.01, 0.1, 1, 10 mm) and succinate (0, 0.04, 0.4, 4, 20 mm), no inhibitory effect of MMA on complex II activity was detected (n = 8, Fig. 1A). In addition, we could exclude any inhibitory effect of MMA (concentration range, 0.01–10 mm) on the electron-transferring complexes I, III, and IV as well as on ATP synthase (data not shown). Furthermore, we found no effect of propionic acid (up to 10 mm), the decarboxylation product of MMA, on complex II activity. In contrast, the competitive complex II inhibitor MA (0, 0.01, 0.1, 1, 10 mm) revealed an inhibition of complex II activity at varying succinate concentrations (0, 0.04, 0.4, 4, 20 mm), confirming the reliability of our assay (n = 8, Fig. 1B). Next, we investigated whether prolonged incubation with MMA would induce complex II inhibition, in analogy to the suicide inhibitor 3-nitropropionic acid inactivating complex II by covalent binding. However, incubation with MMA (1–10 mm) for 30 min did not decrease complex II activity, whereas 3-nitropropionic acid induced a strong inhibition of this enzyme (n = 8, Fig. 2). A further prolongation of the incubation period (up to 120 min) showed similar results for MMA (data not shown). Evaluation of Artificial Inhibition of Complex II Activity; Relevance of pH Effects and Aging—The pH optimum for complex II activity was determined in SMPs at a range from pH 5 to pH 10 (n = 8). Complex II activity reached a maximum at pH 7.4, whereas pH changes dramatically reduced Vmax (Fig. 3A). The pH dependence of complex II activity was described according to Brandt and Okun (25Brandt U. Okun J.G. Biochemistry. 1997; 36: 11234-11240Crossref PubMed Scopus (89) Google Scholar), revealing a pKA of 6.7 and a pKB of 7.9 (Fig. 3B). Simultaneous experiments with buffered MMA (adjusted to pH 7.4) and unbuffered MMA (0.01 mm (pH 7.4), 0.1 mm (pH 7.4), 1 mm (pH 7.2), 5 mm (pH 5.7), 10 mm (pH 5.1)) revealed a strong decrease in complex II activity at concentrations of 1–10 mm due to a concentration-dependent pH shift (n = 8, Fig. 3C). The concentrations of succinate and oxaloacetate in the test system is of relevance for Vmax. Whereas increasing succinate concentrations have been shown to increase Vmax (see also Fig. 1), oxaloacetate has the opposite effect. Because the relation of these two compounds changes in the SMP dilution in a time-dependent fashion, we investigated whether aging effects would result in a decrease of Vmax. In fact, we found a decrease in complex II activity if the SMP dilution was kept at room temperature for a period of 140 min (n = 8, Fig. 4A). If kept on ice (0 °C, i.e. our standard condition), complex II activity remained stable during this time period (n = 8, Fig. 4A). Because complex II activity correlates with the concentrations of its substrate succinate, we investigated the influence of different succinate concentrations (SMP dilutions kept on ice). At 4 and 20 mm succinate (i.e. 100- and 500-fold Km), complex II activity remained stable for 80 min, whereas at 0.04 and 0.4 mm succinate it rapidly decreased, most likely due to a decrease in succinate and an increase in oxaloacetate concentrations (n = 8, Fig. 4B). Because time-dependent changes in Vmax necessitate a simultaneous measurement of controls, we investigated whether a normalization of complex II activity to (a) simultaneous controls or to (b) non-simultaneous controls (determined at the beginning of each experimental series of 3 h) would result in a misinterpretation of complex II activity measurements at low succinate concentrations. If normalized to simultaneous controls, MMA revealed no inhibitory effect on complex II activity using 0.4 mm succinate (n = 8, Fig. 4c). In contrast, using the same set of data normalization to a non-simultaneous control group, which would not detect aging effects of the control group, resulted in an apparent concentration-dependent decrease of complex II activity by MMA (n = 8, Fig. 4C). Methylmalonic Acid Does Not Affect Mitochondrial Respiration and Oxidative Phosphorylation—Activity measurement of single respiratory chain complexes could not exclude that MMA has an inhibitory effect on associated proteins of the mitochondrial respiratory chain, e.g. on transporter systems. Such effects could be determined by radiometric analysis of the oxidation rate of 14C-labeled substrates and of pyruvate- and succinate-induced ATP production in coupled mitochondria. For this purpose we used 600 × g supernatants from muscle tissue of adult C57Bl/6 mice (n = 6). MMA (1 mm) revealed no effect on the mitochondrial respiration of [1-14C]pyruvate (Fig. 5A), [U-14C]malate (Fig. 5B), or [1,4-14C]succinate (Fig. 5C). Furthermore, ATP production stimulated by pyruvate (Fig. 5D) or succinate (Fig. 5E) was not affected by MMA (1 mm). The same system revealed a good inhibitory response to standard inhibitors of respiratory chain (2-n-decylquinazoline-4-yl-a-mine, antimycin A, malonate, arsenite, atractyloside) and carbonyl cyanide p-chlorophenylhydrazone (data not shown), confirming the reliability of our data. The biochemical hallmark of methylmalonic acidurias is an accumulation and increased urinary excretion of the organic acid MMA. MMA is structurally similar to the competitive complex II inhibitor MA (31Greene J.G. Porter R.H. Eller R.V. Greenamyre J.T. J. Neurochem. 1993; 61: 1151-1154Crossref PubMed Scopus (198) Google Scholar). Neurodegeneration in methylmalonic acidurias in particular affects the globus pallidus, which is also affected in inherited or acquired inhibition of complex II (9Martin J.J. van de Vyver F.L. Scholte H.R. Roodhooft A.M. Martin C.C. Luyt-Houwen L.E. J. Neurol. Sci. 1988; 84: 189-200Abstract Full Text PDF PubMed Scopus (32) Google Scholar, 24Beal M.F. Brouillet E. Jenkins B.G. Ferrante R.J. Kowall N.W. Miller J.M. Storey E. Srivastava R. Rosen B.R. Hyman B. J. Neurosci. 1993; 13: 4181-4191Crossref PubMed Google Scholar, 31Greene J.G. Porter R.H. Eller R.V. Greenamyre J.T. J. Neurochem. 1993; 61: 1151-1154Crossref PubMed Scopus (198) Google Scholar). Thus, it seemed reasonable to suggest MMA as an endogenous toxic metabolite inducing neurodegenerative changes via impairment of energy metabolism (7Heidenreich R. Natowicz M. Hainline B.E. Berman P. Kelley R.I. Hillman R.E. Berry G.T. J. Pediatr. 1988; 113: 1022-1027Abstract Full Text PDF PubMed Scopus (129) Google Scholar, 12Wajner M. Coelho J.C. J. Inherited Metab. Dis. 1997; 20: 761-768Crossref PubMed Scopus (68) Google Scholar). In fact, administration of MMA in vitro and in vivo induced neuronal cell damage involving ionotropic glutamate receptors and oxidative stress (13McLaughlin B.A. Nelson D. Silver J.A. Erecinska M. Chesselet M.F. Neuroscience. 1998; 86: 276-290Crossref Scopus (95) Google Scholar, 14Kölker S. Ahlemeyer B. Krieglstein J. Hoffmann G.F. J. Inherited Metab. Dis. 2000; 23: 355-358Crossref PubMed Scopus (27) Google Scholar, 15Okun J.G. Hörster F. Farkas L.M. Feyh P. Hinz A. Sauer S. Hoffmann G.F. Unsicker K. Mayatepek E. Kölker S. J. Biol. Chem. 2002; 277: 14674-14680Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar, 16de Mello C.F. Begnini J. Jimenez-Bernal R.E. Rubin M.A. de Bastiani J. da Costa Jr., E. Wajner M. Brain Res. 1996; 721: 120-125Crossref PubMed Scopus (68) Google Scholar, 17Narasimhan P. Sklar R. Murrell M. Swanson R.A. Sharp F.R. J. Neurosci. 1996; 16: 7336-7346Crossref PubMed Google Scholar). Although two previous studies from the same group demonstrated inhibition of complex II activity by MMA (10Dutra J.C. Dutra-Filho C.S. Cardozo S.E.C. Wannmacher C.M.D. Sarkis J.J.F. Wajner M. J. Inherited Metab. Dis. 1993; 16: 147-153Crossref PubMed Scopus (70) Google Scholar, 11Brusque A.M. Borba Rosa R. Schluck P.F. Dalcin K.B. Ribeiro C.A. Silva C.G. Wannmacher C.M. Dutra-Filho C.S. Wyse A.T. Briones P. Wajner M. Neurochem. Int. 2002; 40: 593-601Crossref PubMed Scopus (101) Google Scholar), we could not confirm this finding in a recent study (15Okun J.G. Hörster F. Farkas L.M. Feyh P. Hinz A. Sauer S. Hoffmann G.F. Unsicker K. Mayatepek E. Kölker S. J. Biol. Chem. 2002; 277: 14674-14680Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar). In contrast, we showed that MMA-induced effects are likely to be indirect, involving the intracellular formation of the competitive complex II inhibitor MA and 2-methylcitric acid, a compound with multiple inhibitory effects on the tricarboxylic acid cycle (32Cheema-Dhadli S. Leznoff C.C. Halperin M.L. Pediatr. Res. 1975; 9: 905-908PubMed Google Scholar). Thus, we suggest that MMA-induced inhibition of complex II activity in the previous studies might have been the result of intracellular formation of MA and 2-methylcitrate. To confirm our hypothesis that MMA has no direct effects on the mitochondrial respiratory chain, we investigated MMA using spectrophotometric analysis of complex II activity in SMPs and radiometric analysis of the mitochondrial respiration of 14C-labeled substrates (pyruvate, malate, succinate). Furthermore, we studied under which experimental conditions complex II inhibition by MMA could be artificially induced. In fact, we could exclude any direct effects of MMA on single complex II activity and [1,4-14C]succinate respiration. Furthermore, succinate-stimulated ATP production was not affected by MMA. Thus, these results exclude any relevant effects of MMA on complex II activity. It has been suggested that MMA inhibited the transmitochondrial malate carrier at millimolar concentrations in rat liver mitochondria (33Halperin M.L. Schiller C.M. Fritz I.B. J. Clin. Invest. 1971; 50: 2276-2282Crossref PubMed Scopus (53) Google Scholar). In this study, radiometric analysis of [U-14C]malate respiration in 600 × g supernatants from mice muscle revealed only a small, but insignificant decrease by 1 mm MMA. An effect on the malate carrier at higher concentrations might be theoretically interesting; however, it is questionable whether this effect has any relevance for the pathophysiology of methylmalonic acidurias. Apart from this, MMA was shown to inhibit pyruvate carboxylase (34Oberholzer V.G. Levin B. Burgess E.A. Young W.F. Arch. Dis. Child. 1967; 42: 492-504Crossref PubMed Scopus (242) Google Scholar) and Na+/K+-ATPases (35Wyse E.L Streck A.T. Barros S.V. Brusque A.M. Zugno A.I. Wajner M. Neuroreport. 2000; 11: 2331-2334Crossref PubMed Scopus (119) Google Scholar). MMA has no inhibitory effect on the respiratory chain function, in particular complex II activity, under the standardized conditions used in this study. However, we could identify some important variables of this enzymatic assay that must be carefully controlled to avoid false-positive inhibitory responses. First of all, the pH should be kept at the optimum for this method (pH 7.4), and all compounds tested should be adequately buffered to avoid pH shifts and, concomitantly, changes in complex II activity. Furthermore, simultaneous measurements of controls and subsequent normalization of the data to these control groups must be performed during the experimental series, in particular if low succinate concentrations are used. To prevent a time-dependent decrease in Vmax during the experiments, saturating concentrations of succinate (4–20 mm) should be used, and the SMP dilution should be kept on ice. It cannot be excluded that additional variables have an important influence on complex II activity. However, if complex II activity is standardized using the standard procedure described above, the reliability of this assay is very high. In conclusion, we could confirm the hypothesis that MMA exerts no direct effects on the mitochondrial respiratory chain and seemingly is not the major toxic metabolite in methylmalonic acidurias. The recent study stresses our previous concept of a synergistic inhibition of respiratory chain and tricarboxylic acid cycle by propionyl-CoA and its alternative products, in particular 2-methylcitrate and MA (15Okun J.G. Hörster F. Farkas L.M. Feyh P. Hinz A. Sauer S. Hoffmann G.F. Unsicker K. Mayatepek E. Kölker S. J. Biol. Chem. 2002; 277: 14674-14680Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar, 32Cheema-Dhadli S. Leznoff C.C. Halperin M.L. Pediatr. Res. 1975; 9: 905-908PubMed Google Scholar). We are grateful to U. Brandt (Dept of Biochemistry I, Molecular Bioenergetics, University of Frankfurt, Germany) for the kind gift of the complex I inhibitor 2-n-decylquinazolin-4-yl-amine. We thank S. Exner-Camps for excellent technical assistance.